The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Muñiz, Javier ^a   Gómez Doblas, Juan J ^b   Santiago Pérez, María I ^c   Lekuona Goya, Iñaki ^d   Murga Eizagaetxebarría, Nekane ^e   de Teresa Galván ß, Eduardo ^b   Cruz Fernández, José M ^f   Castro Beiras, Alfonso ^a,g  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c ODDS   (Spain)

^d HOSPITAL DE GALDAKAO   (Spain)

^e HOSPITAL DE BASURTO   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; EXERCISE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HOSPITAL DISCHARGE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE;

ACUTE CORONARY SYNDROME; AGED; BODY MASS INDEX; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HUMANS; HYPERTENSION; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; RISK FACTORS; SMOKING; SPAIN;

EID: 78549244136     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-137     Document Type: Article

References (31)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. Writing Committee to Revise the 1999 ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2004, 44:671-719. 10.1016/j.jacc.2004.07.002, 15358045.
2. Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in US hospitals as reflected by standarized measures. N Engl J Med 2005, 353:255-264. 10.1056/NEJMsa043778, 16034011.
3. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, . EUROASPIRE Study Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II and III surveys in eight European countries. Lancet 2009, 373:929-40. 10.1016/S0140-6736(09)60330-5, 19286092, EUROASPIRE Study Group.
4. De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Carrasco JL, Navarro A, . en nombre del Grupo de Investigadores del estudio PREVESE La prevención secundaria del infarto de miocardio en España. Estudio PREVESE. Rev Esp Cardiol 1997, 50:406-15. en nombre del Grupo de Investigadores del estudio PREVESE.
5. Freire Castroseiros E, Muñiz García J, Castro Beiras A, . por el grupo de trabajo del estudio RIGA Análisis del uso adecuado de los bloqueadores beta en el postinfarto. Rev Esp Cardiol 2001, 54:1277-82. por el grupo de trabajo del estudio RIGA.
6. EUROASPIRE I and II Group Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II. Lancet 2001, 357:995-1001. 10.1016/S0140-6736(00)04235-5, 11293642, EUROASPIRE I and II Group.
7. De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Sellers G, . en nombre del Grupo de Investigadores del estudio PREVESE II Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II. Rev Esp Cardiol 2002, 55:801-9. en nombre del Grupo de Investigadores del estudio PREVESE II.
8. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Avezum A. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002, 23:1177-89. 10.1053/euhj.2001.3081, 12127920.
9. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM. Long-term adherence to evidence based secondary prevention therapies in coronary artery disease. Circulation 2006, 113:203-212. 10.1161/CIRCULATIONAHA.105.505636, 16401776.
10. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term morality after acute myocardial infarction. JAMA 2006, 297:177-186.
11. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006, 166:1842-1847. 10.1001/archinte.166.17.1842, 17000940.
12. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease. The Heart and Soul Study. Arch Intern Med 2007, 167:1798-1803. 10.1001/archinte.167.16.1798, 2789555, 17846400.
13. Feldstein AC, Smith DH, Perrin N, Yang X, Rix M, Raebel MA, Magid DJ, Simon SR, Soumerai SB. Improved therapeutic monitoring with several interventions. A randomized trial. Arch Intern Med 2006, 166:1848-1854. 10.1001/archinte.166.17.1848, 17000941.
14. Smith DH, Kramer JM, Perrin N, Platt R, Roblin DW, Lane K, Goodman M, Nelson WW, Yang X, Soumerai SB. A randomized trial of direct-to-patient communication to enhance adherence to beta blocker therapy following myocardial infarction. Arch Intern Med 2008, 168:477-483. 10.1001/archinternmed.2007.132, 18332291.
15. Muñiz Garcia J, Gomez Doblas JJ, Santiago Perez MI, de Teresa Galvan E, Cruz Fernandez JM, Castro Beiras A. Effect of a Simple Educational Program for Physicians on Adherence to Secondary Prevention Measures After Discharge Following Acute Coronary Syndrome. The CAM Project. Rev Esp Cardiol 2004, 57:1017-1028. 10.1157/13068162, 15544750.
16. Aronow HD, Novaro GM, Lauer MS, Brennan DM, Lincoff AM, Topol EJ, Kereiakes DJ, Nissen SE. In-Hospital Initiation of Lipid-Lowering Therapy After Coronary Intervention as a Predictor of Long-term Utilization A Propensity Analysis. Arch Intern Med 2003, 163:2576-2582. 10.1001/archinte.163.21.2576, 14638557.
17. De Velasco JA, Cosín J, Oya M, De Teresa E, . en nombre del grupo de investigadores del estudio PRESENTE Programa de intervención para mejorar la prevención secundaria del infarto de miocardio. Resultados del estudio PRESENTE. Rev Esp Cardiol 2004, 57:146-54. 10.1157/13057265, 14967110, en nombre del grupo de investigadores del estudio PRESENTE.
18. Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med 2008, 168:485-491. 10.1001/archinte.168.5.485, 18332293.
19. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol 2007, 50(7):e1-e157. 10.1016/j.jacc.2007.02.013, 17692738.
20. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC. Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2004, 44(3):671-719. 10.1016/j.jacc.2004.07.002, 15358045.
21. Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, Etchells EE. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 2005, 165:424-429. 10.1001/archinte.165.4.424, 15738372.
22. Coleman EA, Smith JD, Raha D, Min S. Post-hospital medication discrepancies: prevalence, types, and contributing system-level and patient-level factors. Arch Intern Med 2005, 165:1842-184736. 10.1001/archinte.165.16.1842, 16157827.
23. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008, 117:1028-36. 10.1161/CIRCULATIONAHA.107.706820, 18299512.
24. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, . EUROASPIRE Study Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. The Lancet 2009, 373:929-940. EUROASPIRE Study Group.
25. Waters D, Brotons C, Chiang CW, Ferrieres J, Foody JA, Jukema J, Santos RD, Verdejo J, Messig M, McPherson R, Seung KB, Tarasenko L, . for the Lipid Treatment Assessment Project 2 Investigators Lipid Treatment Assessment Project 2. A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals. Circulation 2009, 120:28-34. 10.1161/CIRCULATIONAHA.108.838466, 19546386, for the Lipid Treatment Assessment Project 2 Investigators.
26. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, Mehra M, ÓConnor CM, Reynolds D, Walsh MN. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J 2007, 154:12-38. 10.1016/j.ahj.2007.03.030, 17584548.
27. Fonarow GC, Yancy CW, Heywood JT, . ADHERE Scientific Advisory Committee, Study Group, and Investigators Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med 2005, 165:1469-1477. 10.1001/archinte.165.13.1469, 16009861, ADHERE Scientific Advisory Committee, Study Group, and Investigators.
28. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002, 288:462-7. 10.1001/jama.288.4.462, 12132976.
29. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002, 288:455-61. 10.1001/jama.288.4.455, 12132975.
30. Rathore SS, Krumholz HM. Differences, disparities, and biases: clarifying racial variations in health care use. Ann Intern Med 2004, 141:635-638.
31. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, McLaughlin B, Morris N, Chu Cheng S, Hauptman PJ, Antman E, Casey L, Asinger R, Gobel F. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996, 15:799-805.